Pacific Biosciences of California Inc (PACB)
1.54
-0.02
(-1.28%)
USD |
NASDAQ |
Apr 23, 11:45
Pacific Biosciences of California Free Cash Flow: -268.02M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -268.02M |
| September 30, 2023 | -274.08M |
| June 30, 2023 | -275.31M |
| March 31, 2023 | -295.88M |
| December 31, 2022 | -280.14M |
| September 30, 2022 | -249.04M |
| June 30, 2022 | -223.57M |
| March 31, 2022 | -176.27M |
| December 31, 2021 | -117.11M |
| September 30, 2021 | -96.89M |
| June 30, 2021 | -73.46M |
| March 31, 2021 | -80.29M |
| December 31, 2020 | 18.46M |
| September 30, 2020 | 14.47M |
| June 30, 2020 | 14.73M |
| March 31, 2020 | 20.66M |
| December 31, 2019 | -81.15M |
| September 30, 2019 | -81.87M |
| June 30, 2019 | -78.05M |
| March 31, 2019 | -75.73M |
| December 31, 2018 | -68.28M |
| September 30, 2018 | -70.50M |
| June 30, 2018 | -77.32M |
| March 31, 2018 | -77.73M |
| December 31, 2017 | -77.95M |
| Date | Value |
|---|---|
| September 30, 2017 | -72.24M |
| June 30, 2017 | -69.32M |
| March 31, 2017 | -74.75M |
| December 31, 2016 | -76.14M |
| September 30, 2016 | -62.18M |
| June 30, 2016 | -60.23M |
| March 31, 2016 | -46.99M |
| December 31, 2015 | -50.90M |
| September 30, 2015 | -65.14M |
| June 30, 2015 | -55.34M |
| March 31, 2015 | -60.97M |
| December 31, 2014 | -53.08M |
| September 30, 2014 | -51.92M |
| June 30, 2014 | -27.00M |
| March 31, 2014 | -29.60M |
| December 31, 2013 | -30.74M |
| September 30, 2013 | -34.73M |
| June 30, 2013 | -71.35M |
| March 31, 2013 | -78.78M |
| December 31, 2012 | -78.52M |
| September 30, 2012 | -76.07M |
| June 30, 2012 | -84.05M |
| March 31, 2012 | -94.92M |
| December 31, 2011 | -112.26M |
| September 30, 2011 | -136.32M |
Free Cash Flow Range, Past 5 Years
-295.88M
Minimum
Mar 2023
20.66M
Maximum
Mar 2020
-135.94M
Average
-96.89M
Median
Sep 2021
Free Cash Flow Benchmarks
| Cerus Corp | -47.76M |
| Axogen Inc | -20.63M |
| AVITA Medical Inc | -39.46M |
| BioSig Technologies Inc | -17.50M |
| Intellia Therapeutics Inc | -408.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -57.56M |
| Cash from Investing (Quarterly) | -66.58M |
| Cash from Financing (Quarterly) | -81.60M |
| Free Cash Flow Per Share (Quarterly) | -0.2229 |
| Free Cash Flow to Equity (Quarterly) | -60.32M |
| Free Cash Flow to Firm (Quarterly) | -56.04M |
| Free Cash Flow Yield | -68.63% |